カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の低侵襲前立腺がん手術市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Minimally Invasive Prostate Cancer Surgery Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO20739）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO20739
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：92
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の低侵襲前立腺がん手術市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

低侵襲前立腺がん手術市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の低侵襲前立腺がん手術の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

低侵襲前立腺がん手術市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・レゼクトスコープ、前立腺用レトラクター、クライオアブレーション装置、カメラ＆ビデオサポート、電気手術器、レーザー、その他

用途別セグメントは次のように区分されます。
・腹腔鏡手術用ロボット、外科手術ブラキセラピー、クライオサージェリー、その他

世界の低侵襲前立腺がん手術市場の主要な市場プレーヤーは以下のとおりです。
・Angiodynamics、Profound Medical、BSD Medical Corporation、Medtronic、Ethicon Endo-Surgery、Olympus Corporation、Siemens Healthcare、Intuitive Surgical、Teleflex

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、低侵襲前立腺がん手術製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な低侵襲前立腺がん手術メーカーの企業概要、2019年～2022年までの低侵襲前立腺がん手術の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な低侵襲前立腺がん手術メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別低侵襲前立腺がん手術の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの低侵襲前立腺がん手術の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での低侵襲前立腺がん手術市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および低侵襲前立腺がん手術の産業チェーンを掲載しています。
・第13、14、15章では、低侵襲前立腺がん手術の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 低侵襲前立腺がん手術の概要
- 種類別分析（2017年vs2021年vs2028年）：レゼクトスコープ、前立腺用レトラクター、クライオアブレーション装置、カメラ＆ビデオサポート、電気手術器、レーザー、その他
- 用途別分析（2017年vs2021年vs2028年）：腹腔鏡手術用ロボット、外科手術ブラキセラピー、クライオサージェリー、その他
- 世界の低侵襲前立腺がん手術市場規模・予測
- 世界の低侵襲前立腺がん手術生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Angiodynamics、Profound Medical、BSD Medical Corporation、Medtronic、Ethicon Endo-Surgery、Olympus Corporation、Siemens Healthcare、Intuitive Surgical、Teleflex
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：レゼクトスコープ、前立腺用レトラクター、クライオアブレーション装置、カメラ＆ビデオサポート、電気手術器、レーザー、その他
・用途別分析2017年-2028年：腹腔鏡手術用ロボット、外科手術ブラキセラピー、クライオサージェリー、その他
・低侵襲前立腺がん手術の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・低侵襲前立腺がん手術のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・低侵襲前立腺がん手術のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・低侵襲前立腺がん手術の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・低侵襲前立腺がん手術の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Minimally Invasive Prostate Cancer Surgery market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Minimally Invasive Prostate Cancer Surgery market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Laparoscopy Robotics accounting for % of the Minimally Invasive Prostate Cancer Surgery global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Resectoscope segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Minimally Invasive Prostate Cancer Surgery include Angiodynamics, Profound Medical, BSD Medical Corporation, Medtronic, and Ethicon Endo-Surgery, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Minimally Invasive Prostate Cancer Surgery market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Resectoscope
Prostatic Retractor
Cryoablation Device
Cameras and Video Support
Electrosurgical Unit
Lasers
Others
Market segment by Application can be divided into
Laparoscopy Robotics
Surgery Brachytherapy Cryosurgery
Others
The key market players for global Minimally Invasive Prostate Cancer Surgery market are listed below:
Angiodynamics
Profound Medical
BSD Medical Corporation
Medtronic
Ethicon Endo-Surgery
Olympus Corporation
Siemens Healthcare
Intuitive Surgical
Teleflex
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Minimally Invasive Prostate Cancer Surgery product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Minimally Invasive Prostate Cancer Surgery, with price, sales, revenue and global market share of Minimally Invasive Prostate Cancer Surgery from 2019 to 2022.
Chapter 3, the Minimally Invasive Prostate Cancer Surgery competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Minimally Invasive Prostate Cancer Surgery breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Minimally Invasive Prostate Cancer Surgery market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Minimally Invasive Prostate Cancer Surgery.
Chapter 13, 14, and 15, to describe Minimally Invasive Prostate Cancer Surgery sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Minimally Invasive Prostate Cancer Surgery Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Minimally Invasive Prostate Cancer Surgery Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Resectoscope
1.2.3 Prostatic Retractor
1.2.4 Cryoablation Device
1.2.5 Cameras and Video Support
1.2.6 Electrosurgical Unit
1.2.7 Lasers
1.2.8 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Minimally Invasive Prostate Cancer Surgery Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Laparoscopy Robotics
1.3.3 Surgery Brachytherapy Cryosurgery
1.3.4 Others
1.4 Global Minimally Invasive Prostate Cancer Surgery Market Size & Forecast
1.4.1 Global Minimally Invasive Prostate Cancer Surgery Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Minimally Invasive Prostate Cancer Surgery Sales in Volume (2017-2028)
1.4.3 Global Minimally Invasive Prostate Cancer Surgery Price (2017-2028)
1.5 Global Minimally Invasive Prostate Cancer Surgery Production Capacity Analysis
1.5.1 Global Minimally Invasive Prostate Cancer Surgery Total Production Capacity (2017-2028)
1.5.2 Global Minimally Invasive Prostate Cancer Surgery Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Minimally Invasive Prostate Cancer Surgery Market Drivers
1.6.2 Minimally Invasive Prostate Cancer Surgery Market Restraints
1.6.3 Minimally Invasive Prostate Cancer Surgery Trends Analysis
2 Manufacturers Profiles
2.1 Angiodynamics
2.1.1 Angiodynamics Details
2.1.2 Angiodynamics Major Business
2.1.3 Angiodynamics Minimally Invasive Prostate Cancer Surgery Product and Services
2.1.4 Angiodynamics Minimally Invasive Prostate Cancer Surgery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Profound Medical
2.2.1 Profound Medical Details
2.2.2 Profound Medical Major Business
2.2.3 Profound Medical Minimally Invasive Prostate Cancer Surgery Product and Services
2.2.4 Profound Medical Minimally Invasive Prostate Cancer Surgery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 BSD Medical Corporation
2.3.1 BSD Medical Corporation Details
2.3.2 BSD Medical Corporation Major Business
2.3.3 BSD Medical Corporation Minimally Invasive Prostate Cancer Surgery Product and Services
2.3.4 BSD Medical Corporation Minimally Invasive Prostate Cancer Surgery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Medtronic
2.4.1 Medtronic Details
2.4.2 Medtronic Major Business
2.4.3 Medtronic Minimally Invasive Prostate Cancer Surgery Product and Services
2.4.4 Medtronic Minimally Invasive Prostate Cancer Surgery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Ethicon Endo-Surgery
2.5.1 Ethicon Endo-Surgery Details
2.5.2 Ethicon Endo-Surgery Major Business
2.5.3 Ethicon Endo-Surgery Minimally Invasive Prostate Cancer Surgery Product and Services
2.5.4 Ethicon Endo-Surgery Minimally Invasive Prostate Cancer Surgery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Olympus Corporation
2.6.1 Olympus Corporation Details
2.6.2 Olympus Corporation Major Business
2.6.3 Olympus Corporation Minimally Invasive Prostate Cancer Surgery Product and Services
2.6.4 Olympus Corporation Minimally Invasive Prostate Cancer Surgery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Siemens Healthcare
2.7.1 Siemens Healthcare Details
2.7.2 Siemens Healthcare Major Business
2.7.3 Siemens Healthcare Minimally Invasive Prostate Cancer Surgery Product and Services
2.7.4 Siemens Healthcare Minimally Invasive Prostate Cancer Surgery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Intuitive Surgical
2.8.1 Intuitive Surgical Details
2.8.2 Intuitive Surgical Major Business
2.8.3 Intuitive Surgical Minimally Invasive Prostate Cancer Surgery Product and Services
2.8.4 Intuitive Surgical Minimally Invasive Prostate Cancer Surgery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Teleflex
2.9.1 Teleflex Details
2.9.2 Teleflex Major Business
2.9.3 Teleflex Minimally Invasive Prostate Cancer Surgery Product and Services
2.9.4 Teleflex Minimally Invasive Prostate Cancer Surgery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Minimally Invasive Prostate Cancer Surgery Breakdown Data by Manufacturer
3.1 Global Minimally Invasive Prostate Cancer Surgery Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Minimally Invasive Prostate Cancer Surgery Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Minimally Invasive Prostate Cancer Surgery
3.4 Market Concentration Rate
3.4.1 Top 3 Minimally Invasive Prostate Cancer Surgery Manufacturer Market Share in 2021
3.4.2 Top 6 Minimally Invasive Prostate Cancer Surgery Manufacturer Market Share in 2021
3.5 Global Minimally Invasive Prostate Cancer Surgery Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Minimally Invasive Prostate Cancer Surgery Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Minimally Invasive Prostate Cancer Surgery Market Size by Region
4.1.1 Global Minimally Invasive Prostate Cancer Surgery Sales in Volume by Region (2017-2028)
4.1.2 Global Minimally Invasive Prostate Cancer Surgery Revenue by Region (2017-2028)
4.2 North America Minimally Invasive Prostate Cancer Surgery Revenue (2017-2028)
4.3 Europe Minimally Invasive Prostate Cancer Surgery Revenue (2017-2028)
4.4 Asia-Pacific Minimally Invasive Prostate Cancer Surgery Revenue (2017-2028)
4.5 South America Minimally Invasive Prostate Cancer Surgery Revenue (2017-2028)
4.6 Middle East and Africa Minimally Invasive Prostate Cancer Surgery Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Minimally Invasive Prostate Cancer Surgery Sales in Volume by Type (2017-2028)
5.2 Global Minimally Invasive Prostate Cancer Surgery Revenue by Type (2017-2028)
5.3 Global Minimally Invasive Prostate Cancer Surgery Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Minimally Invasive Prostate Cancer Surgery Sales in Volume by Application (2017-2028)
6.2 Global Minimally Invasive Prostate Cancer Surgery Revenue by Application (2017-2028)
6.3 Global Minimally Invasive Prostate Cancer Surgery Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Minimally Invasive Prostate Cancer Surgery Sales by Type (2017-2028)
7.2 North America Minimally Invasive Prostate Cancer Surgery Sales by Application (2017-2028)
7.3 North America Minimally Invasive Prostate Cancer Surgery Market Size by Country
7.3.1 North America Minimally Invasive Prostate Cancer Surgery Sales in Volume by Country (2017-2028)
7.3.2 North America Minimally Invasive Prostate Cancer Surgery Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Minimally Invasive Prostate Cancer Surgery Sales by Type (2017-2028)
8.2 Europe Minimally Invasive Prostate Cancer Surgery Sales by Application (2017-2028)
8.3 Europe Minimally Invasive Prostate Cancer Surgery Market Size by Country
8.3.1 Europe Minimally Invasive Prostate Cancer Surgery Sales in Volume by Country (2017-2028)
8.3.2 Europe Minimally Invasive Prostate Cancer Surgery Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Minimally Invasive Prostate Cancer Surgery Sales by Type (2017-2028)
9.2 Asia-Pacific Minimally Invasive Prostate Cancer Surgery Sales by Application (2017-2028)
9.3 Asia-Pacific Minimally Invasive Prostate Cancer Surgery Market Size by Region
9.3.1 Asia-Pacific Minimally Invasive Prostate Cancer Surgery Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Minimally Invasive Prostate Cancer Surgery Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Minimally Invasive Prostate Cancer Surgery Sales by Type (2017-2028)
10.2 South America Minimally Invasive Prostate Cancer Surgery Sales by Application (2017-2028)
10.3 South America Minimally Invasive Prostate Cancer Surgery Market Size by Country
10.3.1 South America Minimally Invasive Prostate Cancer Surgery Sales in Volume by Country (2017-2028)
10.3.2 South America Minimally Invasive Prostate Cancer Surgery Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Minimally Invasive Prostate Cancer Surgery Sales by Type (2017-2028)
11.2 Middle East & Africa Minimally Invasive Prostate Cancer Surgery Sales by Application (2017-2028)
11.3 Middle East & Africa Minimally Invasive Prostate Cancer Surgery Market Size by Country
11.3.1 Middle East & Africa Minimally Invasive Prostate Cancer Surgery Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Minimally Invasive Prostate Cancer Surgery Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Minimally Invasive Prostate Cancer Surgery and Key Manufacturers
12.2 Manufacturing Costs Percentage of Minimally Invasive Prostate Cancer Surgery
12.3 Minimally Invasive Prostate Cancer Surgery Production Process
12.4 Minimally Invasive Prostate Cancer Surgery Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Minimally Invasive Prostate Cancer Surgery Typical Distributors
13.3 Minimally Invasive Prostate Cancer Surgery Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Minimally Invasive Prostate Cancer Surgery Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Minimally Invasive Prostate Cancer Surgery Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Angiodynamics Basic Information, Manufacturing Base and Competitors
Table 4. Angiodynamics Major Business
Table 5. Angiodynamics Minimally Invasive Prostate Cancer Surgery Product and Services
Table 6. Angiodynamics Minimally Invasive Prostate Cancer Surgery Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Profound Medical Basic Information, Manufacturing Base and Competitors
Table 8. Profound Medical Major Business
Table 9. Profound Medical Minimally Invasive Prostate Cancer Surgery Product and Services
Table 10. Profound Medical Minimally Invasive Prostate Cancer Surgery Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. BSD Medical Corporation Basic Information, Manufacturing Base and Competitors
Table 12. BSD Medical Corporation Major Business
Table 13. BSD Medical Corporation Minimally Invasive Prostate Cancer Surgery Product and Services
Table 14. BSD Medical Corporation Minimally Invasive Prostate Cancer Surgery Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Medtronic Basic Information, Manufacturing Base and Competitors
Table 16. Medtronic Major Business
Table 17. Medtronic Minimally Invasive Prostate Cancer Surgery Product and Services
Table 18. Medtronic Minimally Invasive Prostate Cancer Surgery Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Ethicon Endo-Surgery Basic Information, Manufacturing Base and Competitors
Table 20. Ethicon Endo-Surgery Major Business
Table 21. Ethicon Endo-Surgery Minimally Invasive Prostate Cancer Surgery Product and Services
Table 22. Ethicon Endo-Surgery Minimally Invasive Prostate Cancer Surgery Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Olympus Corporation Basic Information, Manufacturing Base and Competitors
Table 24. Olympus Corporation Major Business
Table 25. Olympus Corporation Minimally Invasive Prostate Cancer Surgery Product and Services
Table 26. Olympus Corporation Minimally Invasive Prostate Cancer Surgery Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Siemens Healthcare Basic Information, Manufacturing Base and Competitors
Table 28. Siemens Healthcare Major Business
Table 29. Siemens Healthcare Minimally Invasive Prostate Cancer Surgery Product and Services
Table 30. Siemens Healthcare Minimally Invasive Prostate Cancer Surgery Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Intuitive Surgical Basic Information, Manufacturing Base and Competitors
Table 32. Intuitive Surgical Major Business
Table 33. Intuitive Surgical Minimally Invasive Prostate Cancer Surgery Product and Services
Table 34. Intuitive Surgical Minimally Invasive Prostate Cancer Surgery Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Teleflex Basic Information, Manufacturing Base and Competitors
Table 36. Teleflex Major Business
Table 37. Teleflex Minimally Invasive Prostate Cancer Surgery Product and Services
Table 38. Teleflex Minimally Invasive Prostate Cancer Surgery Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Minimally Invasive Prostate Cancer Surgery Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 40. Global Minimally Invasive Prostate Cancer Surgery Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Minimally Invasive Prostate Cancer Surgery, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Minimally Invasive Prostate Cancer Surgery Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Minimally Invasive Prostate Cancer Surgery Production Site of Key Manufacturer
Table 44. Minimally Invasive Prostate Cancer Surgery New Entrant and Capacity Expansion Plans
Table 45. Minimally Invasive Prostate Cancer Surgery Mergers & Acquisitions in the Past Five Years
Table 46. Global Minimally Invasive Prostate Cancer Surgery Sales by Region (2017-2022) & (K Units)
Table 47. Global Minimally Invasive Prostate Cancer Surgery Sales by Region (2023-2028) & (K Units)
Table 48. Global Minimally Invasive Prostate Cancer Surgery Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Minimally Invasive Prostate Cancer Surgery Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Minimally Invasive Prostate Cancer Surgery Sales by Type (2017-2022) & (K Units)
Table 51. Global Minimally Invasive Prostate Cancer Surgery Sales by Type (2023-2028) & (K Units)
Table 52. Global Minimally Invasive Prostate Cancer Surgery Revenue by Type (2017-2022) & (USD Million)
Table 53. Global Minimally Invasive Prostate Cancer Surgery Revenue by Type (2023-2028) & (USD Million)
Table 54. Global Minimally Invasive Prostate Cancer Surgery Price by Type (2017-2022) & (US$/Unit)
Table 55. Global Minimally Invasive Prostate Cancer Surgery Price by Type (2023-2028) & (US$/Unit)
Table 56. Global Minimally Invasive Prostate Cancer Surgery Sales by Application (2017-2022) & (K Units)
Table 57. Global Minimally Invasive Prostate Cancer Surgery Sales by Application (2023-2028) & (K Units)
Table 58. Global Minimally Invasive Prostate Cancer Surgery Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Minimally Invasive Prostate Cancer Surgery Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Minimally Invasive Prostate Cancer Surgery Price by Application (2017-2022) & (US$/Unit)
Table 61. Global Minimally Invasive Prostate Cancer Surgery Price by Application (2023-2028) & (US$/Unit)
Table 62. North America Minimally Invasive Prostate Cancer Surgery Sales by Country (2017-2022) & (K Units)
Table 63. North America Minimally Invasive Prostate Cancer Surgery Sales by Country (2023-2028) & (K Units)
Table 64. North America Minimally Invasive Prostate Cancer Surgery Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Minimally Invasive Prostate Cancer Surgery Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Minimally Invasive Prostate Cancer Surgery Sales by Type (2017-2022) & (K Units)
Table 67. North America Minimally Invasive Prostate Cancer Surgery Sales by Type (2023-2028) & (K Units)
Table 68. North America Minimally Invasive Prostate Cancer Surgery Sales by Application (2017-2022) & (K Units)
Table 69. North America Minimally Invasive Prostate Cancer Surgery Sales by Application (2023-2028) & (K Units)
Table 70. Europe Minimally Invasive Prostate Cancer Surgery Sales by Country (2017-2022) & (K Units)
Table 71. Europe Minimally Invasive Prostate Cancer Surgery Sales by Country (2023-2028) & (K Units)
Table 72. Europe Minimally Invasive Prostate Cancer Surgery Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Minimally Invasive Prostate Cancer Surgery Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Minimally Invasive Prostate Cancer Surgery Sales by Type (2017-2022) & (K Units)
Table 75. Europe Minimally Invasive Prostate Cancer Surgery Sales by Type (2023-2028) & (K Units)
Table 76. Europe Minimally Invasive Prostate Cancer Surgery Sales by Application (2017-2022) & (K Units)
Table 77. Europe Minimally Invasive Prostate Cancer Surgery Sales by Application (2023-2028) & (K Units)
Table 78. Asia-Pacific Minimally Invasive Prostate Cancer Surgery Sales by Region (2017-2022) & (K Units)
Table 79. Asia-Pacific Minimally Invasive Prostate Cancer Surgery Sales by Region (2023-2028) & (K Units)
Table 80. Asia-Pacific Minimally Invasive Prostate Cancer Surgery Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Minimally Invasive Prostate Cancer Surgery Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Minimally Invasive Prostate Cancer Surgery Sales by Type (2017-2022) & (K Units)
Table 83. Asia-Pacific Minimally Invasive Prostate Cancer Surgery Sales by Type (2023-2028) & (K Units)
Table 84. Asia-Pacific Minimally Invasive Prostate Cancer Surgery Sales by Application (2017-2022) & (K Units)
Table 85. Asia-Pacific Minimally Invasive Prostate Cancer Surgery Sales by Application (2023-2028) & (K Units)
Table 86. South America Minimally Invasive Prostate Cancer Surgery Sales by Country (2017-2022) & (K Units)
Table 87. South America Minimally Invasive Prostate Cancer Surgery Sales by Country (2023-2028) & (K Units)
Table 88. South America Minimally Invasive Prostate Cancer Surgery Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Minimally Invasive Prostate Cancer Surgery Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Minimally Invasive Prostate Cancer Surgery Sales by Type (2017-2022) & (K Units)
Table 91. South America Minimally Invasive Prostate Cancer Surgery Sales by Type (2023-2028) & (K Units)
Table 92. South America Minimally Invasive Prostate Cancer Surgery Sales by Application (2017-2022) & (K Units)
Table 93. South America Minimally Invasive Prostate Cancer Surgery Sales by Application (2023-2028) & (K Units)
Table 94. Middle East & Africa Minimally Invasive Prostate Cancer Surgery Sales by Region (2017-2022) & (K Units)
Table 95. Middle East & Africa Minimally Invasive Prostate Cancer Surgery Sales by Region (2023-2028) & (K Units)
Table 96. Middle East & Africa Minimally Invasive Prostate Cancer Surgery Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Minimally Invasive Prostate Cancer Surgery Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Minimally Invasive Prostate Cancer Surgery Sales by Type (2017-2022) & (K Units)
Table 99. Middle East & Africa Minimally Invasive Prostate Cancer Surgery Sales by Type (2023-2028) & (K Units)
Table 100. Middle East & Africa Minimally Invasive Prostate Cancer Surgery Sales by Application (2017-2022) & (K Units)
Table 101. Middle East & Africa Minimally Invasive Prostate Cancer Surgery Sales by Application (2023-2028) & (K Units)
Table 102. Minimally Invasive Prostate Cancer Surgery Raw Material
Table 103. Key Manufacturers of Minimally Invasive Prostate Cancer Surgery Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Minimally Invasive Prostate Cancer Surgery Typical Distributors
Table 107. Minimally Invasive Prostate Cancer Surgery Typical Customers
List of Figures
Figure 1. Minimally Invasive Prostate Cancer Surgery Picture
Figure 2. Global Minimally Invasive Prostate Cancer Surgery Revenue Market Share by Type in 2021
Figure 3. Resectoscope
Figure 4. Prostatic Retractor
Figure 5. Cryoablation Device
Figure 6. Cameras and Video Support
Figure 7. Electrosurgical Unit
Figure 8. Lasers
Figure 9. Others
Figure 10. Global Minimally Invasive Prostate Cancer Surgery Revenue Market Share by Application in 2021
Figure 11. Laparoscopy Robotics
Figure 12. Surgery Brachytherapy Cryosurgery
Figure 13. Others
Figure 14. Global Minimally Invasive Prostate Cancer Surgery Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 15. Global Minimally Invasive Prostate Cancer Surgery Revenue and Forecast (2017-2028) & (USD Million)
Figure 16. Global Minimally Invasive Prostate Cancer Surgery Sales (2017-2028) & (K Units)
Figure 17. Global Minimally Invasive Prostate Cancer Surgery Price (2017-2028) & (US$/Unit)
Figure 18. Global Minimally Invasive Prostate Cancer Surgery Production Capacity (2017-2028) & (K Units)
Figure 19. Global Minimally Invasive Prostate Cancer Surgery Production Capacity by Geographic Region: 2022 VS 2028
Figure 20. Minimally Invasive Prostate Cancer Surgery Market Drivers
Figure 21. Minimally Invasive Prostate Cancer Surgery Market Restraints
Figure 22. Minimally Invasive Prostate Cancer Surgery Market Trends
Figure 23. Global Minimally Invasive Prostate Cancer Surgery Sales Market Share by Manufacturer in 2021
Figure 24. Global Minimally Invasive Prostate Cancer Surgery Revenue Market Share by Manufacturer in 2021
Figure 25. Minimally Invasive Prostate Cancer Surgery Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 26. Top 3 Minimally Invasive Prostate Cancer Surgery Manufacturer (Revenue) Market Share in 2021
Figure 27. Top 6 Minimally Invasive Prostate Cancer Surgery Manufacturer (Revenue) Market Share in 2021
Figure 28. Global Minimally Invasive Prostate Cancer Surgery Sales Market Share by Region (2017-2028)
Figure 29. Global Minimally Invasive Prostate Cancer Surgery Revenue Market Share by Region (2017-2028)
Figure 30. North America Minimally Invasive Prostate Cancer Surgery Revenue (2017-2028) & (USD Million)
Figure 31. Europe Minimally Invasive Prostate Cancer Surgery Revenue (2017-2028) & (USD Million)
Figure 32. Asia-Pacific Minimally Invasive Prostate Cancer Surgery Revenue (2017-2028) & (USD Million)
Figure 33. South America Minimally Invasive Prostate Cancer Surgery Revenue (2017-2028) & (USD Million)
Figure 34. Middle East & Africa Minimally Invasive Prostate Cancer Surgery Revenue (2017-2028) & (USD Million)
Figure 35. Global Minimally Invasive Prostate Cancer Surgery Sales Market Share by Type (2017-2028)
Figure 36. Global Minimally Invasive Prostate Cancer Surgery Revenue Market Share by Type (2017-2028)
Figure 37. Global Minimally Invasive Prostate Cancer Surgery Price by Type (2017-2028) & (US$/Unit)
Figure 38. Global Minimally Invasive Prostate Cancer Surgery Sales Market Share by Application (2017-2028)
Figure 39. Global Minimally Invasive Prostate Cancer Surgery Revenue Market Share by Application (2017-2028)
Figure 40. Global Minimally Invasive Prostate Cancer Surgery Price by Application (2017-2028) & (US$/Unit)
Figure 41. North America Minimally Invasive Prostate Cancer Surgery Sales Market Share by Type (2017-2028)
Figure 42. North America Minimally Invasive Prostate Cancer Surgery Sales Market Share by Application (2017-2028)
Figure 43. North America Minimally Invasive Prostate Cancer Surgery Sales Market Share by Country (2017-2028)
Figure 44. North America Minimally Invasive Prostate Cancer Surgery Revenue Market Share by Country (2017-2028)
Figure 45. United States Minimally Invasive Prostate Cancer Surgery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Canada Minimally Invasive Prostate Cancer Surgery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Mexico Minimally Invasive Prostate Cancer Surgery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Europe Minimally Invasive Prostate Cancer Surgery Sales Market Share by Type (2017-2028)
Figure 49. Europe Minimally Invasive Prostate Cancer Surgery Sales Market Share by Application (2017-2028)
Figure 50. Europe Minimally Invasive Prostate Cancer Surgery Sales Market Share by Country (2017-2028)
Figure 51. Europe Minimally Invasive Prostate Cancer Surgery Revenue Market Share by Country (2017-2028)
Figure 52. Germany Minimally Invasive Prostate Cancer Surgery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. France Minimally Invasive Prostate Cancer Surgery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. United Kingdom Minimally Invasive Prostate Cancer Surgery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Russia Minimally Invasive Prostate Cancer Surgery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Italy Minimally Invasive Prostate Cancer Surgery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Asia-Pacific Minimally Invasive Prostate Cancer Surgery Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Minimally Invasive Prostate Cancer Surgery Sales Market Share by Application (2017-2028)
Figure 59. Asia-Pacific Minimally Invasive Prostate Cancer Surgery Sales Market Share by Region (2017-2028)
Figure 60. Asia-Pacific Minimally Invasive Prostate Cancer Surgery Revenue Market Share by Region (2017-2028)
Figure 61. China Minimally Invasive Prostate Cancer Surgery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Japan Minimally Invasive Prostate Cancer Surgery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Korea Minimally Invasive Prostate Cancer Surgery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. India Minimally Invasive Prostate Cancer Surgery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Southeast Asia Minimally Invasive Prostate Cancer Surgery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Australia Minimally Invasive Prostate Cancer Surgery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. South America Minimally Invasive Prostate Cancer Surgery Sales Market Share by Type (2017-2028)
Figure 68. South America Minimally Invasive Prostate Cancer Surgery Sales Market Share by Application (2017-2028)
Figure 69. South America Minimally Invasive Prostate Cancer Surgery Sales Market Share by Country (2017-2028)
Figure 70. South America Minimally Invasive Prostate Cancer Surgery Revenue Market Share by Country (2017-2028)
Figure 71. Brazil Minimally Invasive Prostate Cancer Surgery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Argentina Minimally Invasive Prostate Cancer Surgery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Middle East & Africa Minimally Invasive Prostate Cancer Surgery Sales Market Share by Type (2017-2028)
Figure 74. Middle East & Africa Minimally Invasive Prostate Cancer Surgery Sales Market Share by Application (2017-2028)
Figure 75. Middle East & Africa Minimally Invasive Prostate Cancer Surgery Sales Market Share by Region (2017-2028)
Figure 76. Middle East & Africa Minimally Invasive Prostate Cancer Surgery Revenue Market Share by Region (2017-2028)
Figure 77. Turkey Minimally Invasive Prostate Cancer Surgery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Egypt Minimally Invasive Prostate Cancer Surgery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Saudi Arabia Minimally Invasive Prostate Cancer Surgery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. South Africa Minimally Invasive Prostate Cancer Surgery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Manufacturing Cost Structure Analysis of Minimally Invasive Prostate Cancer Surgery in 2021
Figure 82. Manufacturing Process Analysis of Minimally Invasive Prostate Cancer Surgery
Figure 83. Minimally Invasive Prostate Cancer Surgery Industrial Chain
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
Figure 85. Methodology
Figure 86. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の低侵襲手術シミュレータ市場2022年：市場規模予測（～2028年）
  • 世界の低侵襲手術装置市場2022年：市場規模予測（～2028年）
  • 世界の非侵襲性＆低侵襲性皮膚閉鎖装置市場2022年：市場規模予測（～2028年）
  • 最小侵襲麻酔ビデオ喉頭鏡検査のグローバル市場展望 2023年-2029年：充電モード、電池式
  • 世界の低侵襲皮膚剥離機市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO20739 )"世界の低侵襲前立腺がん手術市場2022年：市場規模予測（～2028年）" (英文：Global Minimally Invasive Prostate Cancer Surgery Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。